Michael Byrnes Email

Chief Financial Officer . eFFECTOR Therapeutics

Current Roles

Employees:
34
Revenue:
$5.3M
About
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs). Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences. Each of eFFECTOR's product candidates is designed to act on a single protein that regulates, in a coordinated manner, the expression of multiple functionally related proteins that together drive important biological processes such as immune evasion, stress and inflammatory responses, as well as cell proliferation.
eFFECTOR Therapeutics Address
142 North Cedros Avenue
San Diego, CA
United States
eFFECTOR Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.